换一批TREATMENT OF PATIENTS DIAGNOSED WITH PANCREATIC DUCTAL ADENOCARCINOMRA USING MONOCLONAL ANTIBODIES AGAINST THE EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR)
摘要The present disclosure relates to the field of immunotherapy of cancer, in particular pancreatic ductal adenocarcinoma (PDAC). Means and methods for treatment of a population of PDAC patients suffering from PDAC tumours which express wildtype KRAS, HRAS or NRAS are disclosed. The claimed antibody is Nimotuzumab. The pancreatic cancer preferably does not contain KRAS mutations at position 12, 16, 61, 154.
更多相关知识
申请/专利号
MYPI2020007129A
申请日期
2016-07-27
公开/公告号
公开/公告日
2024-06-10
主分类号
A61K39/395（含有抗原或抗体的医药配制品）
分类号
A61K39/395 C07K16/32 A61K31/7068 C12Q1/6886 C12Q2600/106 G01N2800/52 A61K39/39558 A61P35/00 A61K31/337 A61K31/517 A61K33/24 A61K45/06 A61K33/243 G01N33/57575 C07K16/22 C07K16/32 C12Q1/6886 C07K2317/70 C07K2317/734 C07K2317/76 C07K2317/73 C07K2317/732 C12Q2600/106 C12Q2600/158 A61K2039/505 A61K39/395 A61P35/00 A61K33/243 C07K16/32 A61K31/7068 C12Q1/6886 G01N2800/52 A61K39/395 C12Q2600/106 A61K33/243 G01N33/57575 A61K39/39558 A61P35/00 A61K31/337 A61K31/517 A61K45/06 A61K2039/505 A61K2300/00
申请/专利权人
ONCOSCIENCE AG INNOCIMAB PTE LTD
发明/设计人
学术成果认领
代理人
Jasdeep Singh A/L Arjan Singh
国别省市代码
德国;DE
- 浏览0
- 被引0
- 下载0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
